Special Issues
Cells publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
The Silent Regulators: Non-Coding RNAs in Cell Function and Disease
Deadline: 25 September 2026
Dysregulated Synaptic Plasticity in Chronic Pain: Molecular Mechanisms, Circuit Dysfunction, and Translational Approaches
Deadline: 25 September 2026
Atherosclerosis and Thrombosis: Molecular and Pathological Research Advance
Deadline: 25 September 2026
Breaking the Balance: Cellular Stress, Proteostasis, Aggregates and Neurodegeneration
Deadline: 25 September 2026
Stem Cells and Metabolism in Acute Myeloid Leukemia: Mechanisms, Models, and Therapeutic Opportunities
Deadline: 25 September 2026
New Molecular Perspectives in Pelvic Floor and Genitourinary Disorders
Deadline: 25 September 2026
Natural Products and Their Derivatives Against Human Disease—2nd Edition
Deadline: 25 September 2026
Targeting Metabolic Vulnerabilities to Selectively Eliminate Cancer Cells
Deadline: 29 September 2026
Antioxidants in Redox Homeostasis of Plant Development
Deadline: 30 September 2026
The Cell Biology of Heart Disease
Deadline: 30 September 2026
The Potential of Induced Pluripotent Stem Cells
Deadline: 30 September 2026
Cell Therapeutics for Corneal Diseases
Deadline: 30 September 2026
of 46

